Treatments

Paper that popularized unproven hydroxychloroquine COVID-19 treatment finally retracted

Wed, 2024-12-18 10:40 — mike kraft

https://www.science.org/content/article/infamous-paper-popularized-unproven-covid-19-treatment-finally-retracted

Infamous paper that popularized unproven COVID-19 treatment finally retracted

A 2020 paper that sparked widespread enthusiasm for hydroxychloroquine as a COVID-19 treatment was retracted today, following years of campaigning by scientists who alleged the research contained major scientific flaws and may have breached ethics regulations. The paper was pulled because of ethical concerns and methodological problems, according to a retraction notice.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Paper that popularized unproven hydroxychloroquine COVID-19 treatment finally retracted
Log in or register to post comments

XBB COVID vaccine estimated effective rate: 63% to 68% against more severe illness in kids

Fri, 2024-12-13 12:41 — mike kraft

XBB COVID vaccine estimated to be 63% to 68% effective against more severe illness in kids The adjusted effectiveness of the updated Pfizer/BioNTech COVID-19 XBB vaccine in the 2023-24 US respiratory virus season was 68% and 63% against hospitalization or emergency department (ED) or urgent-care visits among children aged 5 to 11 years and 12 to 17 years, respectively, with an overall effectiveness for both age-groups of 65%, a Kaiser Permanente Southern California (KPSC)-led research team estimates. CIDRAP

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about XBB COVID vaccine estimated effective rate: 63% to 68% against more severe illness in kids
Log in or register to post comments

Many long COVID patients face slim recovery odds as attention fades

Fri, 2024-11-15 11:41 — mike kraft

Many long COVID patients adjust to slim recovery odds as world moves on

...

The best window for recovery is in the first six months after getting COVID-19, with better odds for people whose initial illness was less severe, as well as those who are vaccinated, researchers in the United Kingdom and the United States found

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Many long COVID patients face slim recovery odds as attention fades
Log in or register to post comments

For older patients, Paxlovid cuts COVID hospitalization, death risk and speeds symptom relief --two new studies

Tue, 2024-11-12 10:44 — mike kraft

Paxlovid cuts COVID hospitalization, death risk and speeds symptom relief, studies find Overall, the risk of developing 28 out of 36 long-COVID symptoms lessened when vaccines were effective. CIDRAP

New findings from two studies have tied use of the antiviral drug nirmatrelvir-ritonavir (Paxlovid) to a reduction in COVID-19 hospitalizations and death, as well as to faster resolution of symptoms and less use of healthcare resources.

Benefit seen only in older patients

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Description of US. community health workers in rural areas and small towns

Thu, 2024-11-07 12:04 — mike kraft

Community Health Workers Spread Across the US, Even in Rural Areas - KFF Health News Community health workers are increasingly common in rural areas, where they help patients overcome barriers to accessing care and staying healthy. khnariellez KFF Health News

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Description of US. community health workers in rural areas and small towns
Log in or register to post comments

Explainer: Discussion of misconceptions about COVID and flu vaccines

Thu, 2024-11-07 11:47 — mike kraft

Mayo Clinic Minute: 3 misconceptions about COVID-19 and the flu vaccines - Mayo Clinic News Network Misconceptions about influenza and COVID-19 vaccines may make some people hesitant to roll up their sleeves. Hear from a Mayo Clinic expert. DeeDee Stiepan Mayo Clinic News Network

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Other

Read more about Explainer: Discussion of misconceptions about COVID and flu vaccines
Log in or register to post comments

Nasal swab tests can predict severity of COVID-19 infection --study

Thu, 2024-11-07 11:28 — mike kraft

Nasal swab tests predict COVID-19 disease severity, Emory study finds | Emory University | Atlanta GA New research from Emory University is providing a more precise prediction of COVID-19 severity that can be found by looking at autoantibodies in the nasal cavity, leading to more personalized treatment plans.

... For high-risk individuals, this could provide critical information to inform immediate treatment options, including quickly taking medications like Paxlovid within one week of symptoms to mitigate a severe response.

Country / Region Tags:

General Topic Tags: